E-LIB Suche - Ergebnisse für: Oh, Stephen T.

1

Multiomic profiling reveals metabolic alterations mediating..:

He, Fan ; Laranjeira, Angelo B.A. ; Kong, Tim...
Journal of Clinical Investigation. 134 (2024) 3 - p. , 2024

Link: https://doi.org/10.1172/..

2

Altered erythropoiesis via JAK2 and ASXL1 mutations in myel..:

Collins, Taylor B. ; Laranjeira, Angelo B.A. ; Kong, Tim...
Experimental Hematology. 132 (2024) - p. 104178 , 2024

Link: https://doi.org/10.1016/..

3

Phase 2 study of add-on parsaclisib for patients with myelo..:

Yacoub, Abdulraheem ; Borate, Uma ; Rampal, Raajit K....
Blood Advances. 8 (2024) 6 - p. 1515-1528 , 2024

Link: https://doi.org/10.1182/..

4

Changes in bone marrow fibrosis during momelotinib or ruxol..:

Oh, Stephen T. ; Verstovsek, Srdan ; Gupta, Vikas...
eJHaem. 5 (2024) 1 - p. 105-116 , 2024

Link: https://doi.org/10.1002/..

5

Association between elevated white blood cell counts and th..:

Gerds, Aaron T. ; Mesa, Ruben ; Burke, John M....
Blood. 143 (2024) 16 - p. 1646-1655 , 2024

Link: https://doi.org/10.1182/..

6

Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk:

Tran, Duc ; Beeler, J. Scott ; Liu, Jie...
Clinical Cancer Research. , 2024

Link: https://doi.org/10.1158/..

7

Pseudo‐lymphocytosis caused by circulating megakaryocyte fr..:

Weli, Homayemem ; Frater, John L. ; Shimer, Gail..
International Journal of Laboratory Hematology. , 2024

Link: https://doi.org/10.1111/..

8

A phase I trial of pevonedistat in combination with ruxolit..:

Kong, Tim ; Gaudin, Nicole ; Gordon, Karyn...
Therapeutic Advances in Hematology. 15 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

9

Meaningful Symptomatic Change in Patients With Myelofibrosi..:

Hudgens, Stacie ; Verstovsek, Srdan ; Floden, Lysbeth...
Value in Health. 27 (2024) 5 - p. 607-613 , 2024

Link: https://doi.org/10.1016/..

10

Spatial Mapping of Hematopoietic Clones in Human Bone Marro:

Young, Andrew L. ; Davis, Hannah C. ; Cox, Maggie J....
Blood Cancer Discovery. 5 (2024) 3 - p. 153-163 , 2024

Link: https://doi.org/10.1158/..

11

Comprehensive profiling of clinical JAK inhibitors in myelo..:

Kong, Tim ; Yu, LaYow ; Laranjeira, Angelo B. A....
American Journal of Hematology. 98 (2023) 7 - p. 1029-1042 , 2023

Link: https://doi.org/10.1002/..

12

Symptomatic benefit of momelotinib in patients with myelofi..:

Mesa, Ruben A. ; Hudgens, Stacie ; Floden, Lysbeth...
Cancer Medicine. 12 (2023) 9 - p. 10612-10624 , 2023

Link: https://doi.org/10.1002/..

13

Patient-reported Outcomes and Quality of Life in Anemic and..:

Mesa, Ruben A. ; Harrison, Claire ; Palmer, Jeanne M....
HemaSphere. 7 (2023) 11 - p. e966 , 2023

Link: https://doi.org/10.1097/..

14

POSTER: MPN-295 Avapritinib in Patients With Advanced Syste..:

Gotlib, Jason ; Reiter, Andreas ; Radia, Deepti H....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S193 , 2023

Link: https://doi.org/10.1016/..

15

Pacritinib is a potent ACVR1 inhibitor with significant ane..:

Oh, Stephen T. ; Mesa, Ruben A. ; Harrison, Claire N....
Blood Advances. 7 (2023) 19 - p. 5835-5842 , 2023

Link: https://doi.org/10.1182/..